Liabilities / Assets
56th percentile
Higher debt load relative to assets than 56% of similar nonprofits.
990 • Fiscal year 2023 • EIN 52-1375827
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
56th percentile
Higher debt load relative to assets than 56% of similar nonprofits.
Liabilities / Revenue
64th percentile
Higher debt load relative to revenue than 64% of similar nonprofits.
Net Margin
57th percentile
Higher net margin than 57% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
67th percentile
Faster asset growth than 67% of similar nonprofits.
Revenue Growth
89th percentile
Faster revenue growth than 89% of similar nonprofits.
Assets
Up$12,897,422
Up $1,434,348 (+13%) from 2022
Net Assets
Up$9,811,236
Up $1,261,615 (+15%) from 2022
Liabilities
Up$3,086,186
Up $172,733 (+5.9%) from 2022
Revenue
Up$6,915,898
Up $2,334,431 (+51%) from 2022
Expenses
Up$6,461,742
Up $251,030 (+4.0%) from 2022
Net Income
Up$454,156
Up $2,083,401 (+128%) from 2022
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The national scleroderma foundation's mission is to advance medical research, promote disease awareness, and provide support and education to people with scleroderma, their families and support networks.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.